Peter J. Lovell

Characterization of SB‐269970‐A, a selective 5‐HT₇ receptor antagonist

Jim J. Hagan, Gary Price, Nigel Deeks et al. · British Journal of Pharmacology · 2000 · 281 citations · Full text

A Novel, Potent, and Selective 5-HT₇Antagonist:  (<i>R</i>)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

Peter J. Lovell, Steven M. Bromidge, Steven Dabbs et al. · Journal of Medicinal Chemistry · 2000 · 248 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +14

The identification of potent and selective imidazole-based inhibitors of B-Raf kinase

Andrew K. Takle, Murray J. B. Brown, Susannah Davies et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 189 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +11

(<i>R</i>)-3,<i>N</i>-Dimethyl-<i>N</i>-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide:  The First Selective 5-HT₇Receptor Antagonist

Ian T. Forbes, Steven Dabbs, D. Malcolm Duckworth et al. · Journal of Medicinal Chemistry · 1998 · 102 citations · Full text

Drug Target, Altmetric Attention Score, Pharmacotherapy +16

Synthesis of Ellipticine:  A Radical Cascade Protocol to Aryl- and Heteroaryl-Annulated[<i>b</i>]carbazoles

Jan Pedersen, W. Russell Bowman, M.R.J. Elsegood et al. · The Journal of Organic Chemistry · 2005 · 86 citations

Medicinal Chemistry, Diversity Oriented Synthesis, Engineering +14